Company Filing History:
Years Active: 2014
Title: Susannah Patey: Innovator in Neurodegenerative Disorder Treatments
Introduction
Susannah Patey is a notable inventor based in Merseyside, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of neurodegenerative disorders. Her innovative work is aimed at addressing critical health challenges, including Alzheimer's disease.
Latest Patents
Susannah Patey holds a patent for a pharmaceutical composition designed for the prevention and/or treatment of neurodegenerative disorders. This composition comprises a compound made up of one or more disaccharide units. Each disaccharide unit includes a uronate moiety linked to a glucosamine moiety. Notably, the 2-O atom of the uronate moiety is substituted with a hydrogen atom, while the 6-O atom of the glucosamine moiety is substituted with a sulphate group. Additionally, the 2-N atom of the glucosamine moiety is substituted with an atom or group other than a sulphate group. This composition is particularly preferred for use in the prevention and/or treatment of Alzheimer's disease.
Career Highlights
Susannah Patey is affiliated with the University of Liverpool, where she continues her research and development efforts. Her work has garnered attention for its potential impact on treating neurodegenerative conditions, showcasing her dedication to advancing medical science.
Collaborations
Some of her notable coworkers include Jeremy E Turnbull and Edwin Yates. Their collaborative efforts contribute to the innovative research environment at the University of Liverpool.
Conclusion
Susannah Patey's contributions to the field of neurodegenerative disorder treatments highlight her role as a leading inventor in pharmaceutical innovation. Her work is paving the way for new therapeutic approaches to combat Alzheimer's disease and improve patient outcomes.